If anyone is confused about latest news and about new company HQ, here it is again.
MEDIFIRST SOLUTIONS, INC. ANNOUNCES
UPDATE TO SHAREHOLDERS
CEO announces new corporate headquarters and updates shareholders on other events and developments.
Manalapan, NJ – April 1, 2014 – MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like to take this opportunity to again update shareholders about recent company developments. Stated CEO, Bruce J. Schoengood, “Since our last announcement, we continue to make significant progress on achieving our long and short term company goals. We have been getting many calls from our current shareholders as well as new investors who are excited about our recent company announcements and are pleased with our ongoing level of communication and updates.” Medifirst would like to thank all its shareholders for their support and confidence and will continue to keep investors informed and updated on company progress.
New Corporate Headquarters—
Medifirst has recently stated that the company is seeking a new corporate office and an announcement would be forthcoming. The company currently offers its wellness services in its Boca Raton, FL and Morganville, NJ offices. Medifirst is now pleased to announce a new corporate headquarters in Freehold, NJ. Commented CEO Schoengood, “I am thrilled to be able to continue to expand our operations and have a larger facility with further room for expansion. This now gives us the opportunity to plant our corporate flag and add another strong component to our infrastructure.”
Medical Marijuana Update--
Medifirst has created an advisory board for its recently announced medical and legal marijuana division. Stated CEO Schoengood, I’m pleased to announce the addition of a medical doctor and attorney who have both accepted our invitation to join our newly formed board. In just a few days, we expect to formally introduce our new members.” As the landscape of this fledging industry begins to expand and take shape, Medifirst plans to add industry professionals from all sectors of the legal marijuana business to its advisory board. Continued Schoengood, “Having a board comprised of a diverse group of experts, will give us the opportunity to move swiftly and decisively as opportunities arise and present themselves in this exciting industry.”
For its publishing division, Medifirst has recently announced successful filing of several magazine trademarks including “Marijuana News & Report” and “Colorado Buds”. The company is pleased to announce it has successfully filed its third magazine trademark, “Florida Cannabis”. Commented Schoengood, “We will continue to enter sectors that we think can establish Medifirst as an industry leader with top-tier products. Publishing provides the kind of advertising based vehicle that can bridge sectors from the entire industry all into one product.”
With medical marijuana right around the corner in Florida, Medifirst is in negotiations to launch a brick and mortar food related business. The strategy here, would be to create both a viable business now and one that, because it is already operational and registered, can expeditiously transition into the legal marijuana service industry. Stated Schoengood, “If we can get an early foothold, we hope to be at the front of the line for state approvals and licenses.” With polls showing unprecedented levels of approval for legal marijuana, Florida seems very likely to have its push for legalization to continue to be fast-tracked.
Outlook—
With the first quarter of 2014 in the books, Medifirst is revenue positive and continues on a path of steady growth. Said Schoengood, “We have been very patient putting our infrastructure in place and now we are beginning to see the benefits in terms of revenue and growth.” The company is in the final stages of completing an agreement that would align Medifirst Solutions with one of the most sough-after and prestigious businesses headquartered in the state of Florida. Upon completion of the agreement, Medifirst plans to have a formal announcement in the upcoming days or weeks.
AI
